Valuation : Krka, d. d.

Market Cap 8.05B 9.35B 7.57B 6.92B 12.93B 884B 12.97B 89.58B 34.7B 453B 35.11B 34.35B 1,459B P/E 2026 *
19.2x
P/E 2027 * 18.3x
Enterprise Value 7.38B 8.57B 6.94B 6.34B 11.85B 810B 11.89B 82.13B 31.81B 415B 32.19B 31.49B 1,338B EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.21x
Free-Float
74.74%
Yield 2026 *
3.76%
Yield 2027 * 3.85%
1 day+2.31%
Current month+1.14%
1 month+1.72%
3 months+4.31%
6 months+14.66%
Current year+31.03%
1 week 260
Extreme 260
267
1 month 257.5
Extreme 257.5
267
Current year 202
Extreme 202
270
1 year 174
Extreme 174
270
3 years 104
Extreme 104
270
5 years 80
Extreme 80
270
10 years 48.01
Extreme 48.01
270
Manager TitleAgeSince
Chief Executive Officer 71 2004-12-31
Director of Finance/CFO - 2025-12-31
Chief Tech/Sci/R&D Officer - 2023-02-28
Director TitleAgeSince
Director/Board Member 59 2004-12-31
Director/Board Member 59 2004-12-31
Director/Board Member 73 2009-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+2.31%0.00%+26.67%+153.33% 9.36B
-0.89%-1.09%+19.16%+67.77% 48.26B
-1.72%-1.15%+45.80%+117.34% 40.5B
-0.70%-2.70%-10.84%+11.79% 11.85B
-2.01%-5.96%+10.47%+76.64% 11.83B
+0.08%-4.11%+24.83%+43.80% 7.5B
-1.67%-0.35%+41.04%-11.59% 7.37B
-0.89%-3.09%+18.78%+207.82% 7.28B
-0.16%-2.36%-46.14%+16.28% 5.19B
-1.60%-2.59%+32.54%+102.62% 4.58B
Average -0.72%-2.12%+16.23%+78.58% 15.37B
Weighted average by Cap. -0.97%-2.46%+23.16%+83.37%

Financials

2026 *2027 *
Net sales 2.16B 2.51B 2.03B 1.86B 3.47B 237B 3.49B 24.06B 9.32B 122B 9.43B 9.23B 392B 2.29B 2.66B 2.15B 1.97B 3.68B 251B 3.69B 25.48B 9.87B 129B 9.99B 9.77B 415B
Net income 427M 495M 401M 366M 685M 46.82B 687M 4.75B 1.84B 23.99B 1.86B 1.82B 77.31B 449M 521M 422M 385M 720M 49.24B 723M 4.99B 1.93B 25.23B 1.96B 1.91B 81.3B
Net Debt -670M -778M -630M -575M -1.08B -73.53B -1.08B -7.45B -2.89B -37.67B -2.92B -2.86B -121B -708M -822M -665M -608M -1.14B -77.68B -1.14B -7.87B -3.05B -39.8B -3.09B -3.02B -128B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,300
Date Price Change Volume
26-09-04 €266.00 +2.31% 3,173
26-09-03 €260.00 -0.19% 3,327
26-09-02 €260.50 -1.51% 8,106
26-09-01 €264.50 +0.57% 3,403
26-08-31 €263.00 -1.13% 3,182
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
266.00EUR
Average target price
245.65EUR
Spread / Average Target
-7.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock